You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies

 

Online download statistics by month:

Online download statistics by month: December 2017 to March 2024

AbstractFullPdf
Dec 201723023054
Jan 201821421282
Feb 20181049948
Mar 2018959929
Apr 2018525331
May 2018838542
Jun 2018535414
Jul 2018737318
Aug 2018797917
Sep 2018717125
Oct 201811912124
Nov 201811111126
Dec 201818718717
Jan 201913413322
Feb 201912112318
Mar 2019979724
Apr 2019929226
May 2019706917
Jun 2019858527
Jul 2019696923
Aug 2019454410
Sep 201939385
Oct 2019605913
Nov 2019504810
Dec 2019585712
Jan 2020323113
Feb 2020616118
Mar 2020434312
Apr 2020545414
May 2020303017
Jun 202034337
Jul 2020696913
Aug 2020434316
Sep 2020454515
Oct 2020626219
Nov 2020302911
Dec 2020606023
Jan 2021353316
Feb 2021484819
Mar 2021474711
Apr 2021353511
May 2021505111
Jun 2021434315
Jul 2021242415
Aug 202127279
Sep 2021343413
Oct 2021737131
Nov 2021373722
Dec 2021343410
Jan 2022242513
Feb 2022576824
Mar 2022565816
Apr 2022647119
May 2022596116
Jun 202240369
Jul 2022303112
Aug 202240367
Sep 2022444113
Oct 2022333011
Nov 2022226727
Dec 2022828115
Jan 2023908911
Feb 202347456
Mar 2023434215
Apr 2023282413
May 2023181514
Jun 202325209
Jul 202329289
Aug 2023282714
Sep 202338354
Oct 202361595
Nov 2023323010
Dec 2023272211
Jan 20248811
Feb 2024242310
Mar 2024221941
Total451245231360